| Literature DB >> 28430815 |
Yukio Yamori1,2,3, Miki Sagara2, Yoshimi Arai3, Hitomi Kobayashi3, Kazumi Kishimoto3, Ikuko Matsuno3, Hideki Mori1, Mari Mori1.
Abstract
In the World Health Organization (WHO)-coordinated Cardiovascular Disease and Alimentary Comparison Study, isoflavones (I; biomarker for dietary soy) and taurine (T; biomarker for dietary fish) in 24-hour-urine (24U) were inversely related to coronary heart disease (CHD) mortality. High levels of these biomarkers are found in Japanese people, whose CHD mortality is lowest among developed countries. We analyzed the association of these biomarkers with cardiovascular disease risk in the Japanese to know their health effects within one ethnic population. First, to compare the Japanese intake of I and T with international intakes, the ratios of 24UI and 24UT to creatinine from the WHO Study were divided into quintiles for analysis. The ratio for the Japanese was the highest in the highest quintiles for both I and T, reaching 88.1%, far higher than the average ratio for the Japanese (26.3%) in the total study population. Second, 553 inhabitants of Hyogo Prefecture, Japan, aged 30 to 79 years underwent 24-U collection and blood analyses. The 24UT and 24UI were divided into tertiles and adjusted for age and sex. The highest T tertile, compared with the lowest tertile, showed significantly higher levels of high-density lipoprotein-cholesterol (HDL-C), total cholesterol, 24U sodium (Na) and potassium (K). The highest I tertile showed significantly higher folate, 24UNa and 24UK compared with the lowest tertile. The highest tertile of both T and I showed significantly higher HDL-C, folate, and 24UNa and 24UK compared with the lowest tertile. Thus, greater consumption of fish and soy were significantly associated with higher HDL-C and folate levels, possibly a contributor to Japan having the lowest CHD mortality and longest life expectancy among developed countries. As these intakes were also associated with a high intake of salt, a low-salt intake of fish and soy should be recommended for healthy life expectancy.Entities:
Mesh:
Year: 2017 PMID: 28430815 PMCID: PMC5400241 DOI: 10.1371/journal.pone.0176039
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1The ratio of Japanese in 25 groups divided into the quintiles of 24U T and I, the biomarkers of fish and soy intakes.
Association of tertiles of biomarker of fish intake (24UT) with cardiovascular risks, fasting blood, and 24U in Japanese, Hyogo inhabitants aged 30 to 79 Years.
| Tertile of 24UT/Creatinine ratio, μmol/mmol | P for linear trend | |||
|---|---|---|---|---|
| 1 (low) | 2 | 3 (high) | ||
| Median | 62.9 | 123.0 | 233.6 | |
| Range | 18.8–93.5 | 96.2–159.2 | 159.3–1146.7 | |
| Body mass Index | ||||
| n | 101 | 101 | 101 | |
| Crude | 22.5 ± 0.3 | 22.9 ± 0.3 | 21.9 ± 0.3 | NS |
| Age and gender adjusted | 22.6 ± 0.3 | 22.8 ± 0.3 | 22.0 ± 0.3 | NS |
| Systolic blood pressure (mmHg) | ||||
| n | 101 | 101 | 101 | |
| Crude | 120.4 ± 1.8 | 125.3 ± 1.6 | 122.1 ± 1.6 | NS |
| Age and gender adjusted | 122.0 ± 1.5 | 124.0 ± 1.5 | 121.8 ± 1.5 | NS |
| Diastolic blood pressure (mmHg) | ||||
| n | 101 | 101 | 101 | |
| Crude | 72.1 ± 1.2 | 74.9 ± 1.2 | 72.9 ± 1.1 | NS |
| Age and gender adjusted | 72.5 ± 1.1 | 74.2 ± 1.1 | 73.1 ± 1.1 | NS |
| Serum total cholesterol (mg/dL) | ||||
| n | 101 | 101 | 101 | |
| Crude | 198.3 ± 3.3 | 208.4 ± 3.4 | 213.5 ± 3.7 | p<0.01 |
| Age and gender adjusted | 201.2 ± 3.3 | 207.2 ± 3.3 | 211.8 ± 3.3 | p<0.05 |
| Low-density lipoprotein cholesterol (mg/dL) | ||||
| n | 101 | 101 | 101 | |
| Crude | 117.8 ± 2.9 | 126.8 ± 3.2 | 125.0 ± 3.4 | NS |
| Age and gender adjusted | 120.6 ± 3.0 | 125.4 ± 3.0 | 123.5 ± 3.0 | NS |
| High-density lipoprotein cholesterol (mg/dL) | ||||
| n | 101 | 101 | 101 | |
| Crude | 61.1 ± 1.4 | 60.8 ± 1.3 | 67.3 ± 1.6 | p<0.01 |
| Age and gender adjusted | 60.6 ± 1.4 | 61.5 ± 1.4 | 67.0 ± 1.4 | p<0.001 |
| Triglyceride (mg/dL) | ||||
| n | 96 | 97 | 99 | |
| Crude | 107.8 ± 8.2 | 114.8 ± 7.8 | 95.4 ± 5.2 | NS |
| Age and gender adjusted | 110.8 ± 7.1 | 111.3 ± 7.0 | 95.8 ± 6.9 | NS |
| Folate (ng/mL) | ||||
| n | 101 | 101 | 101 | |
| Crude | 6.5 ± 0.3 | 6.6 ± 0.3 | 7.4 ± 0.4 | NS |
| Age and gender adjusted | 6.7 ± 0.3 | 6.6 ± 0.3 | 7.2 ± 0.3 | NS |
| 24U Salt (g/day) | ||||
| n | 101 | 101 | 101 | |
| Crude | 10.2 ± 0.5 | 11.8 ± 0.5 | 11.6 ± 0.4 | p<0.05 |
| Age and gender adjusted | 10.1 ± 0.4 | 11.6 ± 0.4 | 11.8 ± 0.4 | p<0.01 |
| 24U potassium (g/day) | ||||
| n | 101 | 101 | 101 | |
| Crude | 1.8 ± 0.1 | 2.0 ± 0.1 | 2.1 ± 0.1 | p<0.01 |
| Age and gender adjusted | 1.9 ± 0.1 | 2.0 ± 0.1 | 2.1 ± 0.1 | p<0.05 |
| Sodium/potassium ratio (mEq/mEq) | ||||
| n | 101 | 101 | 101 | |
| Crude | 4.0 ± 0.2 | 4.2 ± 0.2 | 4.1 ± 0.2 | NS |
| Age and gender adjusted | 3.9 ± 0.2 | 4.2 ± 0.2 | 4.2 ± 0.2 | NS |
Abbreviations: n, number; 24U, 24-hour urine; 24UT, 24-hour urinary taurine; T, taurine.
1 From multiple linear regression models for the relationship between 24UI/creatinine ratio and cardiovascular risks, fasting blood and 24U.
2Mean ± standard error (SE) (all such values).
Association of tertiles of biomarker of soy intake (24UI) with cardiovascular risks, fasting blood, and 24U in Japanese, Hyogo inhabitants aged 30 to 79 Years.
| Tertile of 24UI/Creatinine ratio, mmol/mmol | P for linear trend | |||
|---|---|---|---|---|
| 1 (low) | 2 | 3 (high) | ||
| Median | 0.3 | 1.1 | 3.6 | |
| Range | 0.0–0.6 | 0.6–1.9 | 2.0–15.6 | |
| Body mass Index | ||||
| n | 100 | 102 | 101 | |
| Crude | 22.4 ± 0.3 | 22.8 ± 0.3 | 22.2 ± 0.3 | NS |
| Age and gender adjusted | 22.4 ± 0.3 | 22.8 ± 0.3 | 22.2 ± 0.3 | NS |
| Systolic blood pressure (mmHg) | ||||
| n | 100 | 102 | 101 | |
| Crude | 121.9 ± 1.6 | 122.1 ± 1.8 | 123.9 ± 1.6 | NS |
| Age and gender adjusted | 123.2 ± 1.6 | 122.6 ± 1.5 | 121.9 ± 1.6 | NS |
| Diastolic blood pressure (mmHg) | ||||
| n | 100 | 102 | 101 | |
| Crude | 73.5 ± 1.2 | 73.9 ± 1.2 | 72.4 ± 1.1 | NS |
| Age and gender adjusted | 73.1 ± 1.2 | 74.1 ± 1.1 | 72.6 ± 1.2 | NS |
| Serum total cholesterol (mg/dL) | ||||
| n | 100 | 102 | 101 | |
| Crude | 202.7 ± 3.4 | 201.5 ± 3.4 | 216.0 ± 3.6 | p<0.01 |
| Age and gender adjusted | 208.5 ± 3.4 | 202.5 ± 3.3 | 209.2 ± 3.4 | NS |
| Low-density lipoprotein cholesterol (mg/dL) | ||||
| n | 100 | 102 | 101 | |
| Crude | 120.6 ± 3.2 | 119.6 ± 3.1 | 129.3 ± 3.3 | p<0.05 |
| Age and gender adjusted | 125.7 ± 3.1 | 120.6 ± 3.0 | 123.2 ± 3.1 | NS |
| High-density lipoprotein cholesterol (mg/dL) | ||||
| n | 100 | 102 | 101 | |
| Crude | 61.9 ± 1.4 | 62.2 ± 1.6 | 65.0 ± 1.4 | NS |
| Age and gender adjusted | 62.4 ± 1.5 | 62.0 ± 1.4 | 64.8 ± 1.5 | NS |
| Triglyceride (mg/dL) | ||||
| n | 95 | 100 | 97 | |
| Crude | 104.2 ± 6.8 | 105.2 ± 7.3 | 108.3 ± 7.4 | NS |
| Age and gender adjusted | 102.9 ± 7.3 | 106.0 ± 6.9 | 108.7 ± 7.4 | NS |
| Folate (ng/mL) | ||||
| n | 100 | 102 | 101 | |
| Crude | 5.8 ± 0.3 | 6.4 ± 0.3 | 8.4 ± 0.4 | p<0.01 |
| Age and gender adjusted | 6.0 ± 0.3 | 6.4 ± 0.3 | 8.1 ± 0.3 | p<0.01 |
| 24U Salt (g/day) | ||||
| n | 100 | 102 | 101 | |
| Crude | 10.5 ± 0.4 | 11.5 ± 0.4 | 11.6 ± 0.5 | NS |
| Age and gender adjusted | 9.9 ± 0.5 | 11.4 ± 0.4 | 12.3 ± 0.5 | p<0.001 |
| 24U potassium (g/day) | ||||
| n | 100 | 102 | 101 | |
| Crude | 1.7 ± 0.1 | 1.9 ± 0.1 | 2.4 ± 0.1 | p<0.001 |
| Age and gender adjusted | 1.7 ± 0.1 | 1.9 ± 0.1 | 2.3 ± 0.1 | p<0.001 |
| Sodium/potassium ratio (mEq/mEq) | ||||
| n | 100 | 102 | 101 | |
| Crude | 4.5 ± 0.2 | 4.3 ± 0.2 | 3.5 ± 0.2 | p<0.001 |
| Age and gender adjusted | 4.2 ± 0.2 | 4.2 ± 0.2 | 3.8 ± 0.2 | NS |
Abbreviations: n, number; 24U, 24-hour urine; 24UI, 24-hour urinary isoflavones.
1 From multiple linear regression models for the relationship between 24UI/creatinine ratio and cardiovascular risks, fasting blood, and 24U.
2Mean ± standard error (SE) (all such values).
Association of tertiles of biomarkers of fish and soy intakes (24UT, 24UI) with cardiovascular risks, fasting blood, and 24U in Japanese, Hyogo inhabitants aged 30 to 79 Years.
| Combination of tertiles of 24UI/Creatinine ratio and 24UT/Creatinine ratio | P for linear trend | |||
|---|---|---|---|---|
| T1I1 (low) | T2I2 | T3I3 (high) | ||
| Body mass Index | ||||
| n | 37 | 31 | 43 | |
| Crude | 22.2 ± 0.5 | 22.9 ± 0.5 | 21.6 ± 0.6 | NS |
| Age and gender adjusted | 21.8 ± 0.6 | 22.9 ± 0.6 | 21.9 ± 0.5 | NS |
| Systolic blood pressure (mmHg) | ||||
| n | 37 | 31 | 43 | |
| Crude | 119.9 ± 2.8 | 124.7 ± 3.0 | 122.6 ± 2.4 | NS |
| Age and gender adjusted | 121.9 ± 2.6 | 123.7 ± 2.7 | 121.5 ± 2.4 | NS |
| Diastolic blood pressure (mmHg) | ||||
| n | 37 | 31 | 43 | |
| Crude | 70.8 ± 2.0 | 74.0 ± 2.0 | 71.9 ± 1.7 | NS |
| Age and gender adjusted | 71.0 ± 1.8 | 73.6 ± 1.9 | 72.1 ± 1.6 | NS |
| Serum total cholesterol (mg/dL) | ||||
| n | 37 | 31 | 43 | |
| Crude | 194.4 ± 5.3 | 203.5 ± 6.9 | 219.4 ± 6.3 | p<0.01 |
| Age and gender adjusted | 204.5 ± 6.3 | 200.9 ± 6.4 | 212.5 ± 5.6 | NS |
| Low-density lipoprotein cholesterol (mg/dL) | ||||
| n | 37 | 31 | 43 | |
| Crude | 116.8 ± 4.7 | 123.4 ± 6.7 | 132.4 ± 5.4 | p<0.05 |
| Age and gender adjusted | 126.7 ± 5.5 | 120.7 ± 5.5 | 125.8 ± 4.9 | NS |
| High-density lipoprotein cholesterol (mg/dL) | ||||
| n | 37 | 31 | 43 | |
| Crude | 61.4 ± 2.1 | 63.1 ± 2.9 | 67.5 ± 2.3 | NS |
| Age and gender adjusted | 60.1 ± 2.5 | 63.7 ± 2.6 | 68.1 ± 2.3 | p<0.05 |
| Triglyceride (mg/dL) | ||||
| n | 34 | 31 | 43 | |
| Crude | 91.0 ± 10.4 | 99.9 ± 8.0 | 92.5 ± 6.3 | NS |
| Age and gender adjusted | 95.1 ± 8.7 | 97.8 ± 8.5 | 90.8 ± 7.5 | NS |
| Folate (ng/mL) | ||||
| n | 37 | 31 | 43 | |
| Crude | 5.8 ± 0.5 | 6.9 ± 0.5 | 9.5 ± 0.7 | p<0.001 |
| Age and gender adjusted | 6.1 ± 0.7 | 6.8 ± 0.7 | 9.2 ± 0.6 | p<0.001 |
| 24U Salt (g/day) | ||||
| n | 37 | 31 | 43 | |
| Crude | 9.1 ± 0.6 | 12.7 ± 0.9 | 11.9 ± 0.7 | p<0.01 |
| Age and gender adjusted | 8.1 ± 0.8 | 12.9 ± 0.8 | 12.6 ± 0.7 | p<0.001 |
| 24U potassium (g/day) | ||||
| n | 37 | 31 | 43 | |
| Crude | 1.5 ± 0.1 | 2.0 ± 0.1 | 2.5 ± 0.1 | p<0.001 |
| Age and gender adjusted | 1.6 ± 0.1 | 2.0 ± 0.1 | 2.4 ± 0.1 | p<0.001 |
| Sodium/potassium ratio (mEq/mEq) | ||||
| n | 37 | 31 | 43 | |
| Crude | 4.3 ± 0.4 | 4.4 ± 0.3 | 3.4 ± 0.2 | p<0.05 |
| Age and gender adjusted | 3.8 ± 0.3 | 4.5 ± 0.3 | 3.8 ± 0.3 | NS |
Abbreviations: n, number; 24U, 24-hour urine; 24UT, 24-hour urinary taurine; 24UI, 24-hour urinary isoflavones; T, taurine; I, isoflavones.
1From multiple linear regression models for the relationship between 24UT and 24UI and cardiovascular disease risks, fasting blood and 24U.
2Mean ± standard error (all such values).
Fig 2Concommitant fish and soy intake related to 24U salt and potassium excretions and to HDL cholesterol, in comparison with difference in HDL by gender.
Abbreviations: 24U, 24hour urine; K,potassium; HDL,high-density lipoprotein; T1(3),lowest(highest) tertile of 24U taurine/creatinine;I1(3), lowest(highest) tertile of 24U isoflavone/creatinine. a) and b): adjusted for age and gender, c):adjusted for age, gender and hypolipidemic agents, d) adjusted for age.
Fig 3Fish and soy intakes related to serum folate in Japanese, Hyogo inhabitants aged 30–79.
Abbreviations: 24UT, 24hour urinary taurine; 24UI, 24hour urinary isoflavone; T1-3, lowest to highest tertile of 24U taurine/creatinine;I1-3,lowest to highest tertile of 24U isoflavone/creatinine.